Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
0.8497
-0.0153 (-1.77%)
Aug 13, 2025, 4:00 PM - Market closed
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $30.73 million as of August 14, 2025. Its market cap has decreased by -61.77% in one year.
Market Cap
30.73M
Enterprise Value
29.41M
1-Year Change
-61.77%
Ranking
Category
Stock Price
$0.85
Market Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $30.73M, an increase of 1,628.73%. That is a compound annual growth rate of 175.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 31.28M | -27.94% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 572.35B |
| Johnson & Johnson | 415.29B |
| AbbVie | 349.94B |
| UnitedHealth Group | 235.47B |
| AstraZeneca | 229.47B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 227.06B |
| Novo Nordisk | 222.88B |